* Applied Microbiology Inc. received two patents (Nos. 5,516,682and 5,559,096) covering lanthocins, a class of antimicrobial peptideagents used in fighting bacterial infections. One patent relates to arecombinant variant of a lanthocin and the other coverspharmaceutical compositions of the lanthocin, nisin, for treatment ofHelicobacter pylori infections.
* Genelabs Technologies Inc., of Redwood City, Calif., received apatent (No. 5,567,696) covering use of dehydroepiandrosterone, orGL 701, for treatment of systemic lupus erythematosus. The drug waslicensed from Stanford University, of Palo Alto, Calif.
(c) 1997 American Health Consultants. All rights reserved.